AlphaCrest Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-66,066
| Closed | -$534K | – | 1259 |
|
|
2022
Q2 | $534K | Buy |
66,066
+19,811
| +43% | +$160K | 0.03% | 934 |
|
|
2022
Q1 | $642K | Buy |
+46,255
| New | +$642K | 0.04% | 774 |
|
|
2021
Q4 | – | Sell |
-6,982
| Closed | -$237K | – | 1356 |
|
|
2021
Q3 | $237K | Sell |
6,982
-9,018
| -56% | -$306K | 0.01% | 1176 |
|
|
2021
Q2 | $654K | Buy |
16,000
+4,300
| +37% | +$176K | 0.03% | 850 |
|
|
2021
Q1 | $471K | Buy |
+11,700
| New | +$471K | 0.03% | 824 |
|